Preparation and characterization of polyethylenimine-coated Fe3O4-MCM-48 nanocomposite particles as a novel agent for magnet-assisted transfection.

A new type of magnetic nanoparticle was synthesized using mesoporous silica MCM-48 as a template. Magnetite (Fe(3)O(4)) nanocrystals were incorporated onto the MCM-48 silica structure by thermal decomposition of iron(III) acetylacetonate. The particle size of these Fe(3)O(4)-MCM-48 composite particles is around 300 nm with an iron oxide content of ca. 20% w/w. Measurements from SQUID magnetometry suggest that these nanoparticles possess superparamagnetic properties similar to those of Fe(3)O(4) nanoparticles. By coating positively charged polyethylenimine on to the surface, DNA can be bound onto the Fe(3)O(4)-MCM-48 nanoparticles. Transfection studies showed that these PEI-Fe(3)O(4)-MCM-48 particles were highly effective as a transfection reagent, and a 400% increase of transfection efficiency compared with the commercial products was recorded.

[1]  A. E. El Haj,et al.  A triple-layer design for polyethyleneimine-coated, nanostructured magnetic particles and their use in DNA binding and transfection , 2007 .

[2]  Gary Friedman,et al.  Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Dobson,et al.  Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection , 2007 .

[4]  J. Dobson,et al.  DNA delivery using polyethyleneimine (PEI) coated iron oxide-silica mesostructured particles. , 2007 .

[5]  J. Dobson,et al.  Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery , 2006, Gene Therapy.

[6]  D. Fischer,et al.  Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives , 2005, The journal of gene medicine.

[7]  M. Antonietti,et al.  Magnetite Nanocrystals: Nonaqueous Synthesis, Characterization, and Solubility† , 2005 .

[8]  A. Benigni,et al.  Gene therapy: how to target the kidney. Promises and pitfalls. , 2004, Current gene therapy.

[9]  Hao Zeng,et al.  Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.

[10]  D. Fischer,et al.  A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity , 1999, Pharmaceutical Research.

[11]  E. Schlaeger,et al.  Transient gene expression in mammalian cells grown in serum-free suspension culture , 1999, Cytotechnology.

[12]  D. W. Pack,et al.  A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. , 2003, Bioconjugate chemistry.

[13]  C. R. Middaugh,et al.  Biophysical characterization of PEI/DNA complexes. , 2003, Journal of pharmaceutical sciences.

[14]  J. A. George,et al.  Gene therapy progress and prospects: adenoviral vectors , 2003, Gene Therapy.

[15]  J. Rosenecker,et al.  The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery , 2003, Biological chemistry.

[16]  D. Fischer,et al.  Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[17]  I. Schmidt-Wolf,et al.  Non-viral and hybrid vectors in human gene therapy: an update. , 2003, Trends in molecular medicine.

[18]  D. Geddes,et al.  Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis , 2002, Advanced Drug Delivery Reviews.

[19]  Jindrich Kopecek,et al.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. , 2002, Advanced drug delivery reviews.

[20]  Jon Dobson,et al.  Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  Hao Zeng,et al.  Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.

[22]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[23]  P. Wright,et al.  Enzyme immobilisation using siliceous mesoporous molecular sieves , 2001 .

[24]  M. Kaleko,et al.  Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs. , 2001, Blood.

[25]  S. W. Kim,et al.  Development of biomaterials for gene therapy. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  A. Mikos,et al.  Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. , 1999, Journal of biomedical materials research.

[27]  A. Mikos,et al.  Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Roth,et al.  Gene therapy for cancer: what have we done and where are we going? , 1997, Journal of the National Cancer Institute.

[29]  C. Benoist,et al.  A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. , 1996, Human gene therapy.

[30]  David A. Fletcher,et al.  The United Kingdom Chemical Database Service , 1996, J. Chem. Inf. Comput. Sci..

[31]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Alan E. Smith,et al.  Viral vectors in gene therapy. , 1995, Annual review of microbiology.

[33]  L. Sachs,et al.  Non‐viral gene transfer: Applications in developmental biology and gene therapy , 1995, Biology of the cell.

[34]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.